• Goal is to combine PBIO’s patented Ultra Shear Technology (UST) with Phasex’ Supercritical Fluid (SCF) processing to develop stable, water-soluble nanoemulsions
• As part of this collaboration, PBIO and Phasex seek to develop stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil
• CEO of PBIO sees collaboration leading to a ‘Value-add’ for Phasex customers and a highly profitable service model for both PBIO and Phasex

Pressure BioSciences Inc. (OTCQB: PBIO) recently announced a strategic collaboration with Phasex Corporation to develop stable, water-soluble nanoemulsions of nutraceuticals (http://dtn.fm/IWq4E). These nanoemulsions may exhibit improved absorption, greater stability, higher bioavailability and other strategic and medical advantages. The collaboration involves combining PBIO’s patented Ultra Shear Technology (UST) with Phasex’s Supercritical Fluid (SCF) extraction technology.

Emulsions are mixtures of two or more liquids (e.g., oils and water) that cannot be blended into each other without the addition of chemicals called surfactants. Emulsions represent an incredibly large existing market with a wide range of applications, including nutraceuticals, pharmaceuticals, cosmetics, industrial lubricants, paints and even food. Currently, most commercially-available emulsion products contain large oil droplets and high amounts of surfactants, which tend to make these macro- and micro-emulsions unstable and not suitable for human use. Conversely, scientific studies have shown that nanoemulsions (with very small oil droplet sizes) generally exhibit improved absorption, higher bioavailability, greater stability, lower surfactant levels and other clear advantages over macro- and micro-emulsions.

Many nutraceuticals begin as compounds contained in plants. When extracted, these compounds end up in the resulting plant oil. From there, they can be used as an oil or turned into an emulsion. Although there are many ways to extract specific compound-rich plant oil, SCF processing is generally considered the cleanest, safest and most environmentally-friendly method available today. Phasex has been using SCF processing for the extraction of compounds-of-interest from plants for over 40 years, and it is considered to be one of the U.S.’s foremost SCF extraction companies.

In a news release announcing the collaboration, Dr. Val Krukonis, a pioneer in SCF extraction and the founder of Phasex, said, “We are impressed with the potential of UST as a complementary technology to SCF extraction. Several customers are currently seeking new methods to turn hydrophobic oil extracts into stable, water-soluble formulations. UST offers the potential to solve this problem by producing stable nanoemulsions of oil-like products in water. Such formulations could potentially have enormous success in many markets, including inks, industrial lubricants, and cosmetics, as well as in pharmaceuticals and nutraceuticals, such as medically important plant oil extracts.”

Richard T. Schumacher, president and CEO of PBIO, added that, “We believe the ability to subject liquids to UST following the Phasex SCF extraction and purification process would be a highly sought-after ‘Value-add’ for Phasex customers. Rapidly-expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies.” He noted that the collaboration could potentially result in a highly profitable service model for both PBIO and Phasex.

Dr. Edmund Ting, Senior Vice President of Engineering for PBIO, explained that nanoemulsions are currently the focus of research efforts worldwide. “Unfortunately, even with these increased efforts, scale-up to a cost-effective, industrial level nanoemulsion production process remains a significant challenge. To that end, we believe that UST has the potential to work through those challenges, and to become a cost-effective, industrial-level nanoemulsion commercial process,” he noted.

As potentially explosive as UST seems to be, though, it is not the only disruptive technology upon which investors in PBIO need to hang their hat or their potential for future returns on investment. PBIO is also seen disrupting the “cell lysis” market (http://dtn.fm/pCaa4) with one of its new high-tech instruments, the Barocycler 2320EXT, which splits cells, according to the site Equities.com. This product carefully cracks open cells at precise pressures to extract the DNA, RNA, proteins and lipids inside in a safe, exquisitely controlled and highly reproducible manner. All the while, care is taken to minimize the damage to the cell’s constituents in order to make them available to research scientists in the highest quality possible. After all, the results of scientific studies are only as good as the quality of the starting material (DNA, proteins, etc.). Equities.com added that the company’s innovative line of instruments and consumables, based on its patented pressure cycling technology (PCT) platform, could revolutionize how researchers approach their studies. The cell lysis global market is projected to grow to $3.84 billion by 2021, showing a compound annual growth rate (CAGR) of 10.3% from 2016, according to a report by MarketsAndMarkets (http://dtn.fm/hQ2yg).

Pressure BioSciences recently announced record revenue for Q3. See the full news release at http://dtn.fm/BsrK9

For more information, visit the company’s website at www.PressureBiosciences.com

• LTTGF sets sights on $80 billion U.S. lottery market
• Cryptocurrencies and online lottery disruption targeted by LTTGF’s blockchain plans
• Federal Reserve study: non-cash payments hit $178 trillion, led by quick growth of debit cards

LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FSE: 2LG) is positioning itself to excel in a cryptocurrency world as the U.S. and other countries increasingly become cashless.  The Los Angeles-based company is making online lotto gaming with cryptocurrencies attractive to consumers who increasingly make purchases with non-cash methods. LTTGF’s blockchain creation strategy could generate even more growth in this environment by adding a security to transactions utilizing blockchain technology.

LottoGopher recently announced its intention to build and launch applicable blockchain technologies as it relates to online lotteries. As part of this, the company has retained blockchain investor and media strategist Jeff Koyen as an independent adviser (http://dtn.fm/5Zx41). The proposed lottery blockchain could increase trust and visibility in the ownership of the actual ticket, he said, adding that a “Lottery Blockchain” could be beneficial to both traditional and online lotteries. In fact, Bitcoin News Service calls the combination of cryptocurrencies and online gambling a “match made in heaven” (http://dtn.fm/4rJOn).

James Morel, CEO of LottoGopher, said in reference to the development of blockchain technologies for LTTGF’s lottery services, “It has been and will continue to disrupt the way businesses operate in the foreseeable future, and we are in preparations now to leverage this technology for lottery-specific applications.”

LTTGF currently operates in the $6.3 billion California market (http://dtn.fm/oLb6N) as a lottery messenger service that permits buyers to buy state lottery tickets online via credit and debit cards, manage their accounts, and receive the latest state lottery news. Eventually, it plans to be operational in 22 more states within the $80 billion total U.S. national lottery market (http://dtn.fm/ubQQ2).

The Federal Reserve Payments Study of U.S. consumer and business spending habits, released in 2017 (http://dtn.fm/d6PBn), found that non-cash payments reached 144 billion payments totaling $178 trillion in 2015. By value, it saw non-cash payments grow by 3.4% from 2012-2015. As payments by check fell, debit cards grew fastest among credit cards — showing a $2.56 trillion valuation, with an annual growth of 6.8%. Clearly, Americans are spending more with credit and debit cards and less with checks and cash.

LTTGF is laden with celebrities. In addition to board member Kevin Harrington, ex-star of the Shark Tank TV show, its spokesperson is well-known actor William Shatner. Prior, he was a spokesperson for Priceline (NASDAQ: PLCN), whose stock skyrocketed in value during his association.

While Harrington is active on LTTGF’s board, Mark Cuban — the successful entrepreneur and also a Shark on the show — is investing in Unikrn, a blockchain sports betting platform, Fortune reports (http://dtn.fm/GmHR3). At the same time, he is investing in its UnikoinGold cryptocurrency. Last month, CoinDesk reported that Unikrn was awarded a gaming license in Malta, seen as presaging widespread online sports gaming in Europe (http://dtn.fm/NQu34).

For more information, visit the company’s website at www.LottoGopher.com

Let us hear your thoughts: LottoGopher Holdings Inc. Message Board

• Major lithium producers not expected to make up impending shortfalls
• Standard Lithium nearly triples lithium assets to meet demand
• Company expediting activities to exploit global imbalance

The increasing demand and value of lithium have been reflected in the performance of lithium mining stocks over the last year. Lithium stocks have rocketed over the last twelve months propelled by insatiable demand for the alkali metal. Lithium has a broad range of industrial applications, from lubricants to glass and ceramics, alloys for lightweight metals, and now, progressively more, in Li-ion batteries.

Sixty percent of lithium use was used in industrial non-battery applications in 2015 while 25% was used in traditional batteries and fourteen per consumed for use in electric vehicles. Energy storage and e-bikes used less than 1% of output. A 2016 Deutsche Bank Markets Research Report (http://dtn.fm/Q66Fw) projected demand for 2025 is much different, not only in overall demand tonnage, but the percentages each application encompasses. By then the majority of lithium (38%) will be consumed by electric vehicles, 6% used for energy storage, and 14% for e-bikes. It’s no wonder that lithium demand has been projected to grow over 300% in the next six years.

Even with major producers ramping up production, serious shortfalls are expected. Shortages can only be made up by junior miners like Standard Lithium Ltd. (TSXV: SLL) (FRA: S5L) (OTCQX: STLHF). Standard Lithium is rapidly assembling a prodigious portfolio of U.S. based lithium brine assets and actively engaged in the further exploration and development of its Bristol Lake, Brine Project located in the Mojave region of California.  Standard Lithium’s Bristol Lake project initially encompassed 16,600+ acres of placer mineral claims, but with the company’s recently announced MOU with Tetra Technologies, Inc. (NYSE: TTI), they have almost tripled the entire Bristol Dry Lake Lithium Project and now has up to 48,000 acres of placer mineral claims and private property lithium brine assets available for development.

Comprehensive geophysics gravity surveys over the Bristol Lake Project indicate potentially high concentrations of lithium-bearing brines present throughout the company’s mineral lease agreement claims and expansion of nearby assets are expected to produce equally promising results. With permits already in place for extensive brine extraction and processing, Standard Lithium is expediting activities to exploit the huge imbalance and meet the urgent need for new lithium sources.

With enormous market imbalances unlikely to be rectified by major producers, investors interested in riding the lithium wave should consider junior miners like Standard Lithium for potential significant capital appreciation.

For more information about the company, visit http://nnw.fm/standardlithium

• Multibillion AI market projected to grow at CAGR 62.9% from 2016 to 2022
• Company revenues tripled in Q2 over same period last year
• 100 billion data computations made daily with 2 million user sessions per month
• Order backlog stands at $3 million and is expected to grow
• Platform’s AI engine publishes more than 3,000 daily articles with major media channel partners

AnalytixInsight (TSX.V: ALY) (OTCQB: ATIXF), an artificial intelligence (AI) company, is transforming numerical data into real-time narratives supporting financial markets around the globe. AnalytixInsight’s three subsidiaries – CapitalCube, MarketWall, and Euclides Technologies Inc. – provide unique platforms used by worldwide stocks across 60 stock exchanges, and by fund managers and investors for reliable content and meaningful financial analytics. The AI market is estimated to be worth USD 16.06 billion by 2022 at a CAGR of 62.9 percent from 2016 to 2022, according to a report by marketsandmarkets (http://dtn.fm/NSf1m). Advancements in dynamic artificial intelligence solutions such as those offered by AnalytixInsight are driving industry growth.

CapitalCube, the company’s deep learning platform, provides comprehensive, natural language company analysis including on-demand fundamental research, portfolio evaluation, predictive analytics, and screening tools on over 50,000 global equities and ETFs. CapitalCube, which attracts over 2 million user sessions monthly, currently processes more than 100 billion data computations daily using its analytics models and logical arguments to generate insights. The platform’s AI engine publishes more than 3,000 daily articles under partnership agreements with various financial entities that include Euronext, Thomson Reuters, The Wall Street Journal, and Yahoo Finance. AnalytixInsight is also pursuing blockchain offerings to enhance CapitalCube’s AI platform, along with partner relationships as it adds to its user base through channel partners.

AnalytixInsight’s custom-built Robo Advisor matches client risk to an ideal portfolio mix using a robust technology that frequently rebalances to maintain a desired risk profile. Its specialized screening tools comb through a universe of stocks and ETFs providing technical analysis and charting, maintaining a Know-Your-Client system to achieve an ideal portfolio mix tied to specific investors. CapitalCube is multi-language capable, highly customizable and can generate reports, earnings analysis, graphs, trend charts and numeric tables displays in PDF file format. A unique scoring system establishes performance score ratings for fundamentals, earnings and dividends while evaluating and forecasting the probability of a share buyback and the ability of a company to make acquisitions or to be acquired.

MarketWall is a seamless smart technology app that provides access to financial data as it ties real time stock trading data and company analysis from CapitalCube and a trading platform. MarketWall is available on 60 million devices thanks to partnerships with the best players in the financial and technology industries including Samsung, Intesa Sanpaolo, Netrange Miia, and major Smart TV producers. This app’s comprehensive stock price trading data and company analysis is a stepping stone to enable complete trade execution on a secure mobile platform. MarketWall is a FinTech mobile app for the stock trading and mobile banking sectors.

Workflow analytics are handled by Euclides Technologies Inc., an expert system integrator for Field Service Management (FSM) solutions. This subsidiary of AnalytixInsight Inc., headquartered in Cambridge, Massachusetts, offers a proven track record of providing expert services to large global corporations, touching over 100,000 field service personnel working worldwide. The team at Euclides is known for its creativity in developing custom solutions to meet uniquely complex business issues.

AnalytixInsight’s AI technology is scalable and extendable to virtually any data-driven industry such as e-commerce, services, communications, healthcare, insurance or government.

For more information, visit the company’s website at www.AnalytixInsight.com.

• Global cannabis market to hit $31 billion by 2021
• Diverse portfolio positioned along the cannabis and hemp value chains
• Completed financing for 30,000 sq. ft. greenhouse cultivation facility
• Wholly-owned subsidiary, HempSMART™, currently has CBD-based wellness products available for sale

A new report from market analyst the Brightfield Group, featured in Forbes (http://dtn.fm/7Jdp1), estimates that global sales of cannabis will climb to $31.4 billion by 2021. The U.S., which “currently drives 90 percent of global cannabis sales,” will dominate this international business. In turn, a large share of the U.S. cannabis market will undoubtedly go to one of the six biggest economies in the world, the state of California. Marijuana Company of America, Inc. (OTC: MCOA) is a publicly traded company that was established in 2015 in California by Don Steinberg and Charles Larsen to execute their vision of creating an umbrella over a diverse portfolio of cannabis- and hemp-based companies. MCOA has already established a commanding presence at various points in the cannabis and industrial hemp cannabidiol (CBD) markets, as well as the related services supply chain.

In September 2017, MCOA entered into a joint venture with Global Hemp Group Inc. (OTC: GBHPF) (CSE: GHG), a Canadian public company, focused on conducting an industrial hemp pilot program in New Brunswick, Canada (http://dtn.fm/ZPJl0). MCOA will be collaborating with Global Hemp Group to assist in the eventual development of a commercial industrial hemp cultivation project. Currently, the companies are conducting the first phase of hemp cultivation trials, the results of which will be used to establish commercial cultivation in 2018. In the first year of the joint venture, MCOA has shared the costs of the ongoing hemp trial, provided its expertise in developing hemp cultivation and granted a right of first refusal for Global Hemp’s output. The project is also receiving research support from Collège Communautaire du Nouveau Brunswick (CCNB) located in Bathurst, New Brunswick, and cultivation consulting from Space Cowboys, Inc.

MCOA recently announced, earlier this month, that it has completed the financing of $800,000 in cash and 15 million shares of the company’s common stock in full satisfaction of the amended terms of its joint venture agreement with Bougainville Ventures, Inc. (http://dtn.fm/npT9m), which calls for an equal split of equity and profits. Under the agreement, BV will contribute its expertise in the construction and management of a 30,000 sq. ft. greenhouse facility to accommodate a Tier-3 production and processing I-502 tenant that has decades of experience and a proven track record of consistency and quality. Initiative 502, passed in 2012, allowed for the cultivation, sale and adult use of cannabis in Washington State.

Also under the MCOA umbrella is wholly-owned subsidiary hempSMART™, Inc., which is committed to bringing high quality CBD-based products to market through its affiliate marketing program. HempSmart Brain, formulated with clinically studied nootropic and adaptogenic ingredients, and hempSMART Full Spectrum Drops, formulated as a sublingual product with enhanced bioavailability, are currently available for shipping across the United States at www.hempSMART.com. Meanwhile, MCOA’s supply chain partners are already established, with inventory purchase contracts in place and customer support centers trained and ready to assist customers.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

Let us hear your thoughts: Marijuana Company of America, Inc. Message Board

• Cobalt may be ready for huge run up
• 75% of Li-ion batteries will contain cobalt by 2020
• First Cobalt positioned as a global cobalt resource company

When presented with a serious market imbalance, savvy investors often look tangentially at the impacts of the imbalance to achieve outsized capital gains. In a severe gasoline shortage, an investor may take positions in electric vehicle manufacturers knowing that long gasoline will be a crowded trade and that gasoline shortages will ripple through the market till it affects EV makers. A similar case can now be made for cobalt. Even though cobalt has risen over the last year, it may hold greater returns than lithium. Most investors are keenly aware of the vast impending shortages anticipated for lithium. In expectation of the imminent imbalance in the lithium markets, smart money has poured into lithium stocks, driving up prices to record highs, with many gaining well over 100% in the last year.

Almost as important for lithium-ion batteries, cobalt hasn’t appreciated at the same pace. It’s projected that 75 percent of lithium-ion batteries will contain cobalt by 2020 (http://dtn.fm/Gq99C). Demand is predicted to sky-rocket because of cobalt’s unique properties that allow electric cars to greatly extend range between charges. Already widely used for super-alloys in turbines, space vehicles, rocket engines and power plants, the importance of cobalt is underscored by the U.S. Defense Logistics Agency’s designation of lithium cobalt oxide and lithium nickel cobalt aluminum oxide compounds as strategic for national interests. As a result, the agency has been stockpiling cobalt since 2014.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) is rapidly assembling one of the largest pure-play cobalt portfolios in the world. The company holds interests in key mineral rights in a region that boasts historic production of 50 million pounds of cobalt and 600 million ounces of silver mined over a 60-year period. Cobalt is produced as a by-product of mining other metals like nickel, copper or, in this case, silver. First Cobalt’s location is easily accessible and has excellent infrastructure nearby. First Cobalt holds one of only four fully-permitted cobalt extraction refineries in Canada and, given deals in play, the company is likely to soon control over 10,000 hectares of prospective land and 50 historic mining operations in Canada.

Currently, the global cobalt market is largely dependent on the Democratic Republic of Congo. With a long history of political instability and violence, the Democratic Republic of Congo accounted for more than half the world’s production in 2016. Extremely concerned about secure and steady supply chains, cobalt end users, especially EV makers, are looking for safe, stable cobalt resources. This factor, combined with impending supply and demand imbalances, could easily drive more attention toward First Cobalt. Savvy investors looking for outsized capital appreciation should take note of the cobalt market.

For more information, visit the company’s website at www.FirstCobalt.com

Let us hear your thoughts: First Cobalt Corp. Message Board

• Shanghai, Beijing, Shenzhen and Guangzhou are metropolitan markets targeted for MOXC’s growth
• China’s population is the world’s largest; goal is to convert its Moxian+ Business and Moxian+ User app platforms from free to paid
• Report: 1.39 billion mobile phone users registered in China, makes it largest globally

Moxian, Inc. (NASDAQ: MOXC) is targeting four key cities in China as it seeks new revenue streams from its two paid app platforms: Moxian+ Business and Moxian+ User. It seeks sales from subscriptions to these apps. Revenue streams also include financial processing commissions through its UnionPay module and, to its business clients in the Online-to-Offline (O2O) market, sales of sophisticated purchase analytics defining targeted and customized online advertising opportunities.

As it seeks to bring its Moxian+ User consumers closer to its Moxian+ Business clients, MOXC finds that these large metropolitan cities provide valuable mobile app businesses and consumer purchasers in the O2O market. That market is estimated this year at $78.4 billion, according to iResearch (http://dtn.fm/x6buA).

MOXC’s two Moxian apps were formerly free — now they are being converted to paid, designed to drive revenues as well. MOXC is a Shenzhen, China-based development stage company, which is aiming to convert its Moxian+ Business app clients from free to paid. It offers to consumers on the Moxian+ User app social media platforms, games and offers prizes in its own Mo-Points and Mo-Coins.

MOXC is focusing on major metropolitan cities in China to achieve its goals: Shenzhen, Beijing, Shanghai and Guangzhou. These population centers are key to marketing to mobile users in China’s enormous population. More important for MOXC, it is the biggest global mobile phone market with 1.39 billion registered users, according to research firm Statista® (http://dtn.fm/nLqH2).

Shenzhen is located in Southern China and has a population of nearly 10.8 million. It is a major financial center and has a modern communication, trade and transportation infrastructure. It houses a Special Economic Zone in China and is home to a number of hi-tech companies. To MOXC, it is a perfect place to market its apps that bring consumers and businesses together. It is one of China’s wealthiest cities.

With a population of 21.5 million as of 2016, Beijing is one of the country’s fastest-growing and wealthiest cities. Its high rise buildings and large population make it a sophisticated metropolitan market — a perfect target for MOXC to market its Moxian+ Business and Moxian+ User apps. Online delivery services, like those in the Moxian+ apps, thrive in this demographic.

Shanghai is China’s largest city, at once a financial hub and a draw for tourists. It had a population of 24.2 million in 2015 and communications and information systems have flourished here. Businesses — such as those attracted by the paid MOXC+ Business app — range from restaurants to entertainment.

Guangzhou has an economy driven by private business. It has a highly-educated population, which bodes well for sophisticated mobile phone apps and the success of the O2O market. Retail sales are growing in the double digits and it has an extensive manufacturing base.

For more information, visit the company’s website at www.Moxian.com

• Management, R&D team boasts decades of industry leadership
• Pipeline includes therapies targeting chronic pain, nausea, inflammation, muscle spasms, epilepsy and Post Traumatic Stress Disorder
• Unique result-driven strategy strongly positions Veritas in the medical marijuana industry

Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is an emerging pharmaceutical and IP development company publicly traded in Canada, the United States and Germany. Through its recently acquired 80 percent stake in Cannevert Therapeutics Ltd., also known as Veritas’ R&D arm, the company is clinically profiling various marijuana cultivars to pharmacologically connect unique strains with specific disease conditions. Veritas Pharma’s goal is to perform clinical trials to prove the efficacy of the designated lead cannabis strains and to market the clinically effective cultivars as prescription medicines in a fast-track protocol.

Veritas Pharma’s management and R&D team comprises decades of pharmaceutical, clinical and scientific research expertise into several key industry leaders. Lui Franciosi, PhD, who has over 20 years of experience conducting pharmaceutical and medical device studies in academia and industry, leads the company as its CEO. In addition to a team of trained technicians and students working out of academic facilities, Veritas Pharma is pleased to have a renowned group of scientists on board to lead its research efforts. Team members hold 10 PhDs/MD licenses with expertise in chemistry, pharmacology and clinical trials.

Veritas Pharma’s mission is to develop and commercialize the most effective cannabis strains, backed by clinical data. This innovative research and development path aims to solve the critical need for real science to support claims surrounding medical marijuana. The company’s approach, combined with its strategic alliances, will effectively address the medical community’s concerns over the complexities of cannabis potency, efficacy, quality and content in the nearly 800 marijuana strains currently known in the world. Opportunities for innovation and scientific advancement related to the field of cannabis therapeutics will accelerate the knowledge base and provide a valuable alternative to the global opioid market that is estimated at nearly U.S. $35 billion. A growing negative opinion regarding the use of opioids for pain will continue to drive the need for alternative medical applications such as those provided by cannabis.

Veritas Pharma’s clinical cannabis development pipeline includes R&D for chronic pain, nausea, inflammation, muscle spasms, epilepsy and Post Traumatic Stress Disorder. The strategic alliance formed with Cannevert and its scientists will enable Veritas to be at the forefront of developing new and unique strains of medicinal cannabis. These plants, which they plan to patent protect for a variety of unmet medical needs, are destined to help patients suffering with chronic and debilitating symptoms of a variety of medical issues. Over 250 experiments have been performed so far with another 150 pharmacological and biological studies conducted. Veritas Pharma has also entered into an agreement with Sechelt Organic Marijuana Inc., which has a Licensed Producer application pending with Health Canada, to acquire 100 percent ownership in the company.

Results of the company’s research to date illustrate Veritas’ unique place in the medical marijuana industry. The company’s focus on the biological effect of the actual spectrum of cannabinoids sets Veritas apart as it seeks to patent and protect results-driven strains.

For more information, visit the company’s website at www.VeritasPharmaInc.com

• Increasing demand for alternative fuel vehicles
• Alternative fuel automotive products compatible with Clean Cities program
• LPG and CNG cost less than gasoline or diesel

Greenkraft, Inc. (OTCQB: GKIT) is driving in line with U.S. government energy policy. Since 2008, the Santa Ana, California-based manufacturer of alternative fuel automotive products has been at the forefront of the drive to introduce cleaner, greener, more efficient products in the transportation market. This mission aligns with U.S. government policy to make cities cleaner by reducing harmful vehicle emissions. Greenkraft’s commercial trucks are powered by a variety of alternative fuels. Spearheaded by the U.S. Department of Energy, the Clean Cities program has been a catalyst for transportation projects that advance U.S. energy independence, transform local markets, support regional economic development and reduce air pollution.

Launched in 1993, Clean Cities is a collaborative program between government and industry, designed to reduce petroleum consumption in the transpor­tation sector. Its ultimate aim is to cut emission of greenhouse gases by this reduction of petroleum use in the auto sector, and the program has set a goal to ‘displace 2.5 billion gallons of petroleum annually, by 2020’. The hope is that this ambitious objective will be achieved by advancing and promoting the use of alternative fuels and vehicles, idle reduction technologies, hybrid electric vehicles, improved fuel blends and better fuel economy. All this is right up Greenkraft’s alley. The company manufactures eco-friendly trucks, as well as alternative fuel systems and engines that are more efficient than other products currently on the market.

Greenkraft’s range of commercial trucks are ideal for food services, electrical contractors, construction, pest control, plumbing, vending, landscaping, and many more industrial applications. They have a gross vehicle weight rating (GVWR) that comprises 14,500 lbs, 15,950 lbs and 17,950 lbs for the G1; 19,500 lbs for the G2; 26,000 lbs for the G3 and 33,000 lbs for the G4. All models are powered by a General Motors 6.0 liter V8. Maximum power for the G1 and G2 is 323 horsepower at 4,600 rpm, while for the G3 and G4 it is 375 horsepower at 3,200 rpm. Fuel options of all models are compressed natural gas (CNG), liquid propane or gasoline. CNG is mainly methane obtained from natural gas, oil wells and coal beds that has been compressed to a pressure of around 200 times normal atmospheric pressure, while propane is typically obtained as a by-product of natural gas processing or petroleum refining.

Natural gas associations, natural gas producers and utilities like the Southern California Gas Company (SoCalGas) are also part of the Clean Cities project. They provide much-needed data on the cost benefits of alternative fuels. For example, a recent study by SoCalGas showed that vehicles powered by CNG offered substantial advantages over vehicles powered by gasoline or diesel (http://dtn.fm/2HoAD).

Greenkraft is currently enjoying a dramatic surge in demand for its trucks from various fleet operators all across the country, as the company recently announced (http://dtn.fm/50kDi). This increased interest is due to the many government incentives (tax credits and deductions) available to companies that switch to alternative energy trucks. Moreover, Greenkraft controls nearly all of the market share in the clean energy truck market. The company is the only manufacturer offering trucks that run on both clean energy CNG and LPG. Both of these fuels are in ample supply. The U.S. is now the world’s largest producer and exporter of LPG, and it has, since 2009, surpassed Russia as the world’s top producer of natural gas. In light of these statistics, there is no doubt that Greenkraft is on the right track.

For more information, visit the company’s website at www.GreenkraftInc.com

Let us hear your thoughts: Greenkraft, Inc. Message Board

• Announces formation of new Canadian subsidiary Ovation Science Inc.
• Agreement forged with Lighthouse Strategies, LLC, regarding exclusive use of patented topical and transdermal formulations in select U.S. markets
• Licensing agreement recently made with Canopy Growth Corp. for exclusive rights in Canada

Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC (http://dtn.fm/SLyx4). The agreement, made through Ovation, stipulates that Lighthouse will have exclusive use of the company’s patented topical and transdermal formulations for select markets in the United States.

Via Lighthouse’s technology division and in collaboration with the San Diego-based Advocacy Research Center (ARC), Lighthouse plans to introduce Ovation’s topical and transdermal products formulated with its patented drug delivery system, Invisicare®. In doing this, Lighthouse intends to foster the development of safe, healthy and lifestyle-integrated treatments coupled with accurate time-released dosing.

Cannabiniers, an established technology and brand management company and Lighthouse subsidiary, will conduct the national distribution of products and brands. Cannabiniers is a pioneer in the cannabis industry, offering revolutionary, patented technologies. In distributing Ovation’s topical products in the U.S., Cannabiniers will leverage its branding prowess and its expertise in local, regional and national cannabis markets.

In working with Ovation, Cannabiniers further aims to normalize consumption and help integrate cannabis into the daily lives of patients and consumers—something Cannabiniers has done with its own brands.

Ovation Science Inc. has been founded in order to better serve the needs of licensees, as well as to focus on specific product development within the cannabis market. This subsidiary has been granted the exclusive global right to all products formulated using Skinvisible’s patented Invisicare® technology with cannabis and hemp seed oil.

In September 2017, Skinvisible also forged a licensing agreement with Canopy Growth Corp., the largest cannabis company in the world, for exclusive rights for Canada and the right of first refusal in other countries outside Canada and the U.S. where cannabis is legal. Ovation has been assigned this license agreement with Canopy.

Skinvisible’s game-changing Invisicare® platform is a patented polymer technology that enhances topical and transdermal drug delivery. When used in topical and transdermal cannabis products, this technology enables improved release and penetration of the product.

Skinvisible has developed over 40 product formulations using Invisicare both in the medical and skincare markets, in addition to being granted 14 patents. The company is focused on licensing its formulations and Invisicare to other companies in the pharmaceutical and cosmeceutical industries.

Like the blockchain and cryptocurrency market, the cannabis market is exploding throughout the world, and Skinvisible’s pioneering technology is poised to be a game-changer for various companies in this space.

For more information, visit the company’s website at www.Skinvisible.com

Let us hear your thoughts: Skinvisible, Inc. Message Board